Dual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of Osteoclasts

Journal of Cellular Physiology

Volumn 231, Issue 3, 2016, Pages 558-567

  Dou, Ce ^a   Li, Jianmei ^a   Kang, Fei ^a   Cao, Zhen ^a   Yang, Xiaochao ^a   Jiang, Hong ^a   Yang, Bo ^a   Xiang, Junyu ^a   Xu, Jianzhong ^a   Dong, Shiwu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; ANTHOCYANIN; CYANIDIN; TNFSF11 PROTEIN, MOUSE;

APOPTOSIS; ARTICLE; BONE DISEASE; BONE METASTASIS; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CELL VIABILITY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; MONOCYTE; MULTIPLE MYELOMA; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; STEM CELL; STROMA CELL; TISSUE ENGINEERING; ANIMAL; BONE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; MOUSE; OSTEOLYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTHOCYANINS; BONE AND BONES; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL FUSION; CELLS, CULTURED; MICE; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 84948964322     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24916     Document Type: Article

References (62)

1. Ang E, Liu Q, Qi M, Liu H, Yang X, Chen H, Zheng M, Xu J. 2011. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-kB and ERK. J Cell Biochem 112:89-97.
2. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson D, Suda T. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kB (RANK) receptors. J Exp Med 190:1741-1754.
3. Boyle W, Simonet W, Lacey D. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
4. Bu S, Lerner M, Stoecker B, Boldrin E, Brackett D, Lucas E, Smith B. 2008. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif Tissue Int 82:475-488.
5. Chen G, Bower KA, Xu M, Ding M, Shi X, Ke ZJ, Luo J. 2009. Cyanidin-3-glucoside reverses ethanol-induced inhibition of neurite outgrowth: Role of glycogen synthase kinase 3 Beta. Neurotox Res 15:321-331.
6. Chen PN, Kuo WH, Chiang CL, Chiou HL, Hsieh YS, Chu SC. 2006. Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chem Biol Interact 163:218-229.
7. Chiu Y, Shao T, Feng C, Mensah K, Thullen M, Schwarz E, Ritchlin C. 2010. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther 12.
8. Choi J, Choi S, Lee S, Lee J, Kim H, Lee S, Lee N. 2013. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway. Cell Signal 25:1222-1227.
9. Ciolli S. 2012. Multiple myeloma. Clin Cases in Miner and Bone Metab 9:150-152.
10. Courtial N, Smink J, Kuvardina O, Leutz A, Göthert J, Lausen J. 2012. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J 26:523-532.
11. Cully M. 2013. Rheumatoid arthritis: Uncoupling bone and cartilage destruction. Nat Rev Rheumatol 9:446.
12. Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y, Xiang J, Xu J, Dong S. 2014. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. Biochimica et biophysica acta 1839:1084-1096.
13. Dreiseitel A, Korte G, Schreier P, Oehme A, Locher S, Domani M, Hajak G, Sand PG. 2009. Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol Res 59:306-311.
14. Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K, Amadori D, Kang Y. 2013. Tumor-induced osteoclast mirna changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 24:542-556.
15. Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, Itoh H, Okawa A, Takeda S. 2012. Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat Med 18:589-594.
16. Ha H, Shim K-S, Kim T, An H, Ma J. 2013. Water extract of dryopteris crassirhizoma attenuates bone loss by suppressing osteoclast differentiation and function. Evidence-based complementary and alternative medicine 2013:852648.
17. Han X, Sterling H, Chen Y, Saginario C, Brown E, Frazier W, Lindberg F, Vignery A. 2000. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 275:37984-37992.
18. Hardcastle AC, Aucott L, Reid DM, Macdonald HM. 2011. Associations between dietary flavonoid intakes and bone health in a Scottish population. J Bone Miner Res 26:941-947.
19. He J, Giusti MM. 2010. Anthocyanins: Natural colorants with health-promoting properties. Annu Rev Food Sci Technol 1:163-187.
20. Huh J-EE, Jung I-TT, Choi J, Baek Y-HH, Lee J-DD, Park D-SS, Choi D-YY. 2013. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-kB in collagen-induced arthritis and bone marrow-derived macrophages. Eur J Pharmacol 698:57-66.
21. Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, Mima T, Katada Y, Miyatake K, Uchiyama Y, Saeki Y. 2006. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res 21:965-976.
22. Iwai K, Ishii M, Ohshima S, Miyatake K, Saeki Y. 2008. Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis. Rheumatol Int 28:225-231.
23. Jean-Gilles D, Li L, Ma H, Yuan T, Chichester CO, 3rd, Seeram NP. 2012. Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model. J Agric Food Chem 60:5755-5762.
24. Jia Y, Hoang M, Jun H-J, Lee J, Lee S-J. 2013. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes. Bioorg Med Chem Lett 23:4185-4190.
25. Khoo HE, Azlan A, Nurulhuda MH, Ismail A, Abas F, Hamid M, Roowi S. 2013. Antioxidative and cardioprotective properties of anthocyanins from defatted dabai extracts. Evid Based Complement Alternat Med 2013:434057.
26. Kim H-J, Hong J, Jung J-W, Kim T-H, Kim J, Kim Y, Kim S-Y. 2010. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression. Int Immunopharmacol 10:1440-1447.
27. Kim H-J, Yoon K-A, Yoon H-J, Hong J, Lee M-J, Lee I-K, Kim S-Y. 2013. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-kB activity and c-Fos induction and prevents inflammatory bone loss in mice. J Leukoc Biol 94:99-107.
28. Kim H-S, Suh K, Sul D, Kim B-J, Lee S, Jung W-W. 2012. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells. Int J Mol Med 29:169-177.
29. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H. 2004. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941-946.
30. Lee S-H, Rho J, Jeong D, Sul J-Y, Kim T, Kim N, Kang J-S, Miyamoto T, Suda T, Lee S-K, Pignolo R, Koczon-Jaremko B, Lorenzo J, Choi Y. 2006. V-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12:1403-1409.
31. Lee SG, Kim B, Yang Y, Pham TX, Park YK, Manatou J, Koo SI, Chun OK, Lee JY. 2013. Berry anthocyanins suppress the expression and secretion of proinflammatory mediators in macrophages by inhibiting nuclear translocation of NF-kB independent of NRF2-mediated mechanism. J Nutr Biochem 25:404-411.
32. Lee SH, Jeong E, Paik SS, Jeon JH, Jung SW, Kim HB, Kim M, Chun MH, Kim IB. 2014. Cyanidin-3-glucoside extracted from mulberry fruit can reduce N-methyl-N-nitrosourea-induced retinal degeneration in rats. Curr Eye Res 39:79-87.
33. Léotoing L, Davicco M-JJ, Lebecque P, Wittrant Y, Coxam V. 2014. The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity. Mol Nutr Food Res 58:1239-1248.
34. Lerner U. 2000. Osteoclast formation and resorption. Matrix Biol 19:107-120.
35. Ma X-NN, Zhou J, Ge B-FF, Zhen P, Ma H-PP, Shi W-GG, Cheng K, Xian CJ, Chen K-MM. 2013. Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro. Planta Medica 79:1501-1508.
36. Mensah KA, Ritchlin CT, Schwarz EM. 2010. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol 223:76-83.
37. Miyamoto T, Suda T. 2003. Differentiation and function of osteoclasts. The Keio J of Med 52:1-7.
38. Moon H-JJ, Ko W-KK, Han SW, Kim D-SS, Hwang Y-SS, Park H-KK, Kwon IK. 2012. Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation. Biochem Biophys Res Commun 418:247-253.
39. Paixão J, Dinis TC, Almeida LM. 2011. Dietary anthocyanins protect endothelial cells against peroxynitrite-induced mitochondrial apoptosis pathway and Bax nuclear translocation: An in vitro approach. Apoptosis 16:976-989.
40. Peng S, Zhang G, Zhang BT, Guo B, He Y, Bakker AJ, Pan X, Zhen W, Hung L, Qin L, Leung WN. 2013. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats. Bone 55:230-240.
41. Remen K, Henning P, Lerner U, Gustafsson J-Å, Andersson G. 2011. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor kB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism. J Biol Chem 286:33084-33094.
42. Rodan G, Martin T. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
43. Roodman G. 1996. Advances in bone biology: The osteoclast. Endocr Rev 17:308-332.
44. Roodman G. 1999. Cell biology of the osteoclast. Exp Hematol 27:1229-1241.
45. Ross JA, Kasum CM. 2002. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19-34.
46. Schippers PG, Prop FJ. 1978. Delphinidin- and cyanidin-chlorides, promotors of cell aggregation in vitro. Cell Biol Int Rep 2:231-235.
47. Srivastava S, Bankar R, Roy P. 2013. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. Phytomedicine 20:683-690.
48. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. 1995. Modulation of osteoclast differentiation by local factors. Bone 17.
49. Swarnkar G, Sharan K, Siddiqui JA, Chakravarti B, Rawat P, Kumar M, Arya KR, Maurya R, Chattopadhyay N. 2011. A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation. Eur J Pharmacol 658:65-73.
50. Takahashi N, Akatsu T, Udagawa N, Sasaki... T. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
51. Teitelbaum S. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
52. Wang JN, Jiang JJ, Xie YM, Wei X, Li JP, Duan JL, Xiong X. 2012. Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis. Chin J Integr Med 18:925-933.
53. Weaver CM, Alekel DL, Ward WE, Ronis MJ. 2012. Flavonoid intake and bone health. J Nutr Gerontol Geriatr 31:239-253.
54. Wong DY, Musgrave IF, Harvey BS, Smid SD. 2013. Acai (Euterpe oleraceae Mart.) berry extract exerts neuroprotective effects against beta-amyloid exposure in vitro. Neurosci Lett 556:221-226.
55. Wu Y-WW, Chen S-CC, Lai W-FTF, Chen Y-CC, Tsai Y-HH. 2013. Screening of flavonoids for effective osteoclastogenesis suppression. Anal Biochem 433:48-55.
56. Xiong J, Onal M, Jilka R, Weinstein R, Manolagas S, O'Brien C. 2011. Matrix-embedded cells control osteoclast formation. Nat Med 17:1235-1241.
57. Xu M, Bower KA, Wang S, Frank JA, Chen G, Ding M, Wang S, Shi X, Ke Z, Luo J. 2010. Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. Mol Cancer 9:285.
58. Xu M, Song Z-G, Xu C-X, Rong G-H, Fan K-X, Cheng J-Y, Zhang W, Jia J-P, Han G, Wang W, Chai W, Liang W-T, Bi W-Z, Wang Y. 2013. Il-17a stimulates the progression of giant cell tumors of bone. Clin Cancer Res 19:4697-4705.
59. Ya-Hui C, Kofi AM, Edward MS, Yawen J, Masahiko T, Changyong F, Loralee AM, David GH, Ben P, Peter CK, Christopher TR. 2012. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 27:79-92.
60. Yang M, Birnbaum M, MacKay C, Mason-Savas A, Thompson B, Odgren P. 2008. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. J Cell Physiol 215:497-505.
61. Yao Y, Yang X, Tian J, Liu C, Cheng X, Ren G. 2013. Antioxidant and antidiabetic activities of black mung bean (Vigna radiata L.). J Agric Food Chem 61:8104-8109.
62. Zhu M, Van Dyke T, Gyurko R. 2013. Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. FASEB J 27:3344-3353.